AlphaYouTC
Insider selling
Terrie Curran sold $28K of Arcutis Biotherapeutics, Inc. (ARQT) stock
Terrie Curran, Dir of Arcutis Biotherapeutics, Inc. (ARQT), sold 1,072 shares of ARQT stock worth $28K, per an SEC Form 4 filed Aug 24, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 20, 2026, 4 days before it was made public.
ARQT has moved +9.6% since the trade date, from $25.35 to $27.78 (Sep 22, 2026 close).
- Traded
- Aug 20, 2026
- Disclosed
- Aug 24, 2026
- Filing delay
- 4 days
- Price since
- +9.6%
- Role
- Dir
- Source
- SEC Form 4
More ARQT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.